Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare disease candidate RVT-802. The investigational tissue-based therapy is for the ...

Chest CT revealed a tumour sized 12 × 9 × 6.5 cm in the anterior mediastinum, suspected of arising from residual thymic tissue, with no signs of invasion into mediastinal structures. A CT-guided ...